Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
GDF15
REST API REST API
Homo sapiens
GDF15 is differentially expressed in 298 experiments: 122 organism parts: kidney, lung, ... (120 more);, 189 disease states: normal, glioblastoma, ... (187 more);, 72 cell types 416 cell lines 40 compound treatments and 66 other conditions.
Synonyms PDF, MIC1, PLAB, PTGFB, NAG-1, MIC-1
Orthologs Gdf15 (Mus musculus)   E1BBL5_BOVIN (Bos taurus)   Gdf15 (Rattus norvegicus)   GDF15 (Xenopus laevis)   GDF15 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term extracellular space, growth factor activity, transforming growth factor beta receptor signaling pathway, extracellular region, cell-cell signaling, cytokine activity, signal transduction
InterPro Term TGF-b_C
UniProt Accession Q99988
Search EB-eye ENSG00000130513
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-MTAB-24, ... (20 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-3860, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, ... (39 experiments)

Factor Value U/D Experiments
HL-60
4
E-GEOD-5258, E-MTAB-37, E-GEOD-24147, E-GEOD-96
AGS
2
E-MTAB-37, E-GEOD-15460
CCRFCEM
2
E-MTAB-37, E-GEOD-24147
LNCaP
2
E-GEOD-14990, E-GEOD-14464
MCF-7
2
E-GEOD-3529, E-GEOD-20081
MOLT4
2
E-MTAB-37, E-MTAB-62
410 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, E-MEXP-66, ... (41 experiments)

Factor Value U/D Experiments
dendritic cell
3
E-GEOD-360, E-GEOD-3982, E-MEXP-2019
endothelial cell
1
2
E-GEOD-3920, E-GEOD-19240, E-GEOD-3998
macrophage
1
2
E-GEOD-5099, E-GEOD-22373, E-GEOD-360
secretory cell
1
E-GEOD-3998
primary blood vessel endothelial cell
1
E-MEXP-66
fetal RPE
1
E-GEOD-18811
66 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-TABM-15, E-GEOD-3678, E-MTAB-62, ... (52 experiments)

Factor Value U/D Experiments
prostate carcinoma
5
E-TABM-26, E-MTAB-62, E-MEXP-2034, E-GEOD-7307, E-MEXP-1327 ... (5 experiments)
colon carcinoma
4
E-MTAB-62, E-MTAB-37, E-GEOD-3726, E-MTAB-57
glioblastoma
1
4
E-GEOD-4290, E-GEOD-6014, E-MTAB-37, E-GEOD-4412, E-MEXP-567 ... (5 experiments)
lung adenocarcinoma
1
3
E-MTAB-62, E-GEOD-2514, E-MEXP-231, E-MTAB-37
acute promyelocytic leukemia
1
3
E-GEOD-995, E-MTAB-62, E-GEOD-1729, E-GEOD-96
dermatomyositis
2
E-GEOD-1551, E-GEOD-5370
183 more value(s).


Compound treatment

studied in E-GEOD-1417, E-GEOD-697, E-TABM-782, E-MEXP-2590, E-MEXP-1958, ... (25 experiments)

Factor Value U/D Experiments
ethanol
2
E-MEXP-2241, E-GEOD-3113
nebivolol
1
E-GEOD-3356
vanadium pentoxide
1
E-GEOD-5339
interferon alpha
1
E-GEOD-1740
TGF
1
E-GEOD-15205
RA
1
E-MEXP-2417
34 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-14359

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, E-GEOD-21340 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-5372, E-GEOD-4619, E-GEOD-2034, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-1614, E-MEXP-2359, E-GEOD-4667, E-MEXP-303, E-MEXP-958, ... (6 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, E-TABM-147, ... (8 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-4025, E-GEOD-7578, E-GEOD-17385, ... (9 experiments)

Genotype
studied in E-TABM-1029, E-MEXP-1996, E-GEOD-17476, E-GEOD-2466, E-GEOD-18005, ... (14 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-2657, E-GEOD-20540, E-GEOD-10315, E-MEXP-1273, E-TABM-263, ... (13 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-1956, E-MEXP-2069, E-GEOD-1926, ... (33 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-GEOD-9723, E-MEXP-561, E-GEOD-980 ... (5 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977

Karyotype
studied in E-GEOD-12662

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Phenotype
studied in E-GEOD-21750, E-GEOD-1657, E-GEOD-2487, E-GEOD-4600

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-1880, E-GEOD-19445

Replicate
studied in E-GEOD-10797, E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-GEOD-1703, E-GEOD-12438, E-MEXP-1509, E-MEXP-101, ... (8 experiments)

Sample preparation
studied in E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

Sex
studied in E-GEOD-1643

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-19815, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561

Processing time: 0.397 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM